Intuitive Surgical Archives - Page 3 of 6

DeviceTalkers assemble for the final Newsmakers of 2022

In this episode, your diligent team of DeviceTalkers assembled to review our Top 10 events, trends and newsmakers of 2022.

Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh and Associate Editor Sean Whooley joined me, DeviceTalks Editorial Director Tom Salemi, for the latest DeviceTalks podcast.

We’ve got some highs — robots, diabetes — and some lows — supply chain, recalls — and a whole lot of interesting things in between. All-in-all, we’re bullish on what’s to come in 2023! And we only mentioned COVID-19 once.

Companies mentioned in our wide-ranging discussion include Abbott, Abiomed, Ambu, Becton Dickinson, Boston Scientific, CMR Surgical, Dexcom, embecta, Intuitive, Johnson & Johnson Medtech, Medtronic, Neuralink, Philips, Senseonics, Stryker, Synchron, Vicarious Surgical, Zimmer Biomet, ZimVie and many more.

You can listen to other DeviceTalks Podcast Network shows at…

Ablation is the next step for Intuitive’s Ion system

The Ion system integrates with Siemens Healthineers’ Cios Spin mobile imaging system

Intuitive is best known for its da Vinci surgical robotics system, but there is buzz around its Ion system with its fully articulating catheter making its way through the lungs for cancer biopsy.

Watch out for the Ion doing even more down the road.

CEO Gary Guthart announced during Intuitive’s Q3 earnings call yesterday evening that the company has obtained German regulatory approval for a clinical study of Ion ablation technology. “We know that Ion can navigate in deep into the lung. We know that surgeons and interventional pulmonologists want to treat tissue there. They want to be able to engage with it one way or another,” Guthart said during the call, transcribed by The Motley Fool.

During a keynote interview today at DeviceTalks West in Santa Clara, California, Guthart said there could be even further opportunities for the technology down the…

Intuitive beats The Street in Q3, increases da Vinci surgical robot base

Intuitive Surgical (Nasdaq:ISRG) shares received a boost on third-quarter results that topped the consensus forecast.

Shares of ISRG skyrocketed after hours. They rose 11.4% to $215.85 apiece after the market closed. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up 3.4%.

The Sunnyvale, California-based company surgical robot maker posted profits of $324 million, or 90¢ per share, on sales of $1.56 billion for the three months ended Sept. 30, 2022, for a 5.3% bottom-line gain on sales growth of 11%.

Adjusted to exclude one-time items, earnings per share were $1.19, 7¢ ahead of Wall Street. Intuitive topped revenue projections, too, as analysts were looking for sales of $1.52 billion.

See Gary Guthart speak at DeviceTalks West Oct. 18-19

Worldwide procedures for the da Vinci surgical robot grew approximately 20% year-over-year. …

These 10 medical device companies have the most revenue per employee

[Image from Unsplash]One way to measure medical device companies’ efficiency is to calculate revenue per employee.

While compiling corporate data for MassDevice and Medical Design & Outsourcing‘s recent Medtech Big 100 report on the largest medical device companies, we took the companies reporting headcounts. Then, we divided the revenue by the number of workers.

When it comes to revenue per employee among medtech companies, three dynamic and growing companies top the list: Hologic, Medline Industries and Intuitive.

Below are the top 10 medical device companies regarding revenue per employee. (And read the full Big 100 report here.)

Company Rev/Employee Hologic* $886,976 Medline Industries $673,333 Intuitive $583,080 Henry Schein $574,121 Owens & Minor $565,625 Carl Zeiss Meditec $563,700 Masimo $563,251 Abiomed $515,104 Insulet $477,739 Accuray $477,677

* Note: Hologic doesn’t report its Q4 earning…

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …

Intuitive misses in Q2, says COVID-19 will likely continue to impact

Intuitive (Nasdaq: ISRG) this evening reported second-quarter results that failed to meet the consensus forecast on Wall Street, with the surgical robotics giant warning that COVID-19 will likely continue to have an adverse impact on da Vinci procedure volumes.

Sunnyvale, California–based Intuitive earned $308 million, or 85¢ per share, off $1.52 billion in revenue for the quarter ended June 30, 2022, representing a 40% bottom-line slide and a top-line gain of 4% compared with the same quarter a year ago.

Adjusted to exclude one-time items, earnings per share were $1.14, a nickel behind The Street, where analysts were looking for EPS of $1.19 on sales of $1.56 billion.

Worldwide da Vinci procedures were up 14% year-over-year in Q2 — but system placements were down 15%.

During a conference call with analysts, top company officials said that trade-ins of da Vinci robots are significantly down because there’s a lower volume of older-generation …

FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy

[Image from Intuitive]Intuitive (Nasdaq:ISRG) announced that the FDA cleared an integration of imaging technology with the Ion robot-assisted bronchoscopy system.

The integration covers a mobile cone-beam CT (CBCT) imaging technology, developed by Siemens Healthineers, called Cios Spin.

Cios Spin offers integrated functionality with Ion to provide 2D and 3D imaging during procedures to help physicians gain confidence around refining Ion’s catheter positioning and help improve biopsy tool placement, according to a news release.

Sunnyvale, California-based Intuitive said early studies demonstrate that Ion enables a diagnostic yield of approximately 80% in studies with a relatively small average nodule size. The integration of Ion with Siemens’ imaging technology could improve the accuracy of biopsy procedures, aiding in the diagnosis of lung cancer, the company said, through the enhancement of a physician’s ability to provide minimally invas…

Creo Medical inks collaboration agreement with Intuitive

Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems.

The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday in New York, ISGR shares are up slightly to $221 apiece on the Nasdaq.

Based in the U.K., Creo is developing and commercializing a suite of electrosurgical medical devices. Its patented Kamaptive technology combines adaptive bipolar radiofrequency (RF) and super high-frequency microwave energy in the CROMA advanced energy platform. Kamaptive can dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue, according to Creo.

Get the full story on our sister site Medical Design & Outsourcing.

Thanks, mom! Medtech leaders reflect on Mother’s Day

[Photo from Aditya Romansa on Unsplash]Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised.

As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve built.

We can never say “thanks” often enough to truly show our gratitude – but one more time can’t hurt.

Get the full story at our sister site, Medical Design & Outsourcing.

Manufacturing matchmaker Fictiv raises $100M for supply chain push

Fictiv co-founder and CEO Dave Evans [Photo courtesy of Fictiv]Fictiv has closed a $100 million Series E funding round, the on-demand manufacturing technology company said today.

Fictiv focuses on “helping companies produce better products,” co-founder and CEO Dave Evans said, with three main offerings: new product development, engineer-to-order products, and maintenance, repair and operations (MRO).

But the company doesn’t actually own any manufacturing equipment, and instead has built a vetted network of 250 manufacturing partners, Evans told DeviceTalks Editorial Director Tom Salemi in an interview. After medical device developers upload their designs to Fictiv’s web-based platform, they get instant pricing and help choosing from different manufacturing methods, standards and prices to find the best fit.

Get the full story at our sister site, Medical Design & Outsourcing.

Intuitive eyes sole-source suppliers as it expands capacity

Intuitive Surgical CFO Jamie Samath [Photo courtesy of Intuitive Surgical]Top executives at Intuitive Surgical (Nasdaq: ISRG) have sole-source suppliers on their minds as they ramp up manufacturing capacity in the face of continued supply chain challenges.

The robotic surgery technology developer’s growth and mindfulness of supply chain resiliency could bring new opportunities for Intuitive’s suppliers — along with competition from others who want in.

Sunnyvale, California–based Intuitive had just more than 10,500 employees at the end of March, CFO Jamie Samath said today on a conference call to discuss Intuitive’s first-quarter financial and operating performance. That employee count is up 26% from the same time a year before, and of the 2,100 new employees, he said about 900 work in manufacturing.

Get the full story at our sister site, Medical Design & Outsourcing.

Intuitive shares dip as first-quarter profits fall short

Intuitive (Nasdaq: ISRG) posted first-quarter financial results that fell short of the consensus forecast on Wall Street for earnings, but exceeded analysts’ expectations for sales.

The Sunnyvale, California–based robotic surgery technology developer reported profits of $366 million, or $1.02 per diluted share, on sales of $1.49 billion for the three months ended March 31, 2022. Compared with Q1 2021, that was a 14% decrease in the bottom line and 15% growth in sales.

Adjusted earnings per share were $1.00, 8¢ short of Wall Street, where analysts were looking for EPS of $1.08 on sales of $1.43 billion. Intuitive noted that it retroactively adjusted prior year EPS information to reflect a three-for-one stock split.

Worldwide procedures performed with Intuitive’s da Vinci surgical robot increased approximately 19% compared to the first quarter of 2021. The COVID-19 pandemic continued to hold back procedures and supply chain disruptions continued, the…